Business

While AI may not end the world the way sci-fi writers imagine, it may very well pull your strings in the near future.

Will fears of climate change cause Great Britain to loosen its restrictions on genetically edited crops?

COVID-19 caused a huge spike in demand for telehealth services, but it opened the door for bad actors as well.

We’re more than a decade into the alt-protein revolution. Will meatless beef ever replace the real thing?

The Wall Street giant’s big bet on Ancestry.com drives home the financial realities facing the consumer genomic revolution.

As Western medicine brings psychedelics into mainstream use, a growing movement is innovating new business models grounded in reciprocity and inclusion.

The race is on to bioengineer carbon-neutral, recyclable, biodegradable, and affordable materials.

These startups are developing new ways to reprogram biology by producing custom genes from scratch.

Neuroscientist David Eagleman aims to give deaf people a new way to hear—and upgrade everyone else’s senses too.

Big indoor farms are attracting big investments. But transforming agriculture might depend on putting nanofarms everywhere — maybe even in your home.